None listed
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: • Males and females of age group 18-50 years • Subjects who are suffering from mild to moderate dandruff and hair loss. • Subjects who are willing to give written informed consent
Exclusion criteria
Exclusion criteria: • Any dermatological condition of the scalp other than hair loss and /or dandruff. • Any prior hair growth procedures (e.g., hair transplant or laser) • History of alcohol or drug addiction • History of skin allergy • Any active skin infection in the scalp area or scarring in the target area. • Subject had ever received radiation therapy to the scalp, or had chemotherapy within the past year. • Subject had participated in any investigational study within the 30 days prior to trial. • A history or the presence of any serious and/or chronic medical condition(s) including psychiatric illnesses] which, in the opinion of the investigator, may cause harm to the individual and/or compromise/confound the study results. • Subjects unwilling or unable to comply with the study procedures
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| â?¢ Reduction in dandruff score [Baseline and visit 4] â?¢ Change in investigator global assessment for hair loss and dandruff (Mild-1, Moderate-2 and severe-3) [Baseline and visit 4] â?¢ Changes in hair objective hair assessments for hair loss- Hair density and Comb test [Baseline and visit 4]. Timepoint: Baseline and visit 4 | — |
Secondary
| Measure | Time frame |
|---|---|
| â?¢ Subjective Assessment by patient using questionnaire [Baseline and visit 4] â?¢ Assessment of adverse events in all visits Timepoint: Baseline and visit 4 | — |
Countries
India
Contacts
Sante Mernaud Pharmaceuticals